(Total Views: 153)
Posted On: 01/16/2019 2:20:01 PM
Post# of 36566
Generex Announces Record & Payment Dates for NuGenerex Immuno-Oncology Stock Dividend
GlobeNewswire•January 16, 2019
-- Share Dividend Declared
-- One share of NuGenerex Immuno-Oncology for every 4 Shares of Generex Biotechnology
MIRAMAR, FL, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the company will dividend Generex shareholders with shares in our wholly-owned subsidiary NuGenerex Immuno-Oncology (formerly Antigen Express), with the ultimate plan to spin out the company on a public exchange. The dividend will be structured for Generex shareholders to receive 1 share of NuGenerex Immuno-Oncology for every 4 shares of Generex Biotechnology with the Record Date of Thursday, January 17, 2019, and a Payment Date of Monday, February 25, 2019.
The stock dividend will result in the issuance of 1 share in NuGenerex Immuno-Oncology for every 4 shares of Generex Biotechnology common stock owned.
This press release does not constitute legal advice. Investors are encouraged to solicit independent legal advice and to consult their independent investment brokerage firms as to record, payment, and ex-dividend dates and the application thereof to trades in the Company’s common stock in the context of the stock dividend.
About Generex Biotechnology Corp.
GlobeNewswire•January 16, 2019
-- Share Dividend Declared
-- One share of NuGenerex Immuno-Oncology for every 4 Shares of Generex Biotechnology
MIRAMAR, FL, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the company will dividend Generex shareholders with shares in our wholly-owned subsidiary NuGenerex Immuno-Oncology (formerly Antigen Express), with the ultimate plan to spin out the company on a public exchange. The dividend will be structured for Generex shareholders to receive 1 share of NuGenerex Immuno-Oncology for every 4 shares of Generex Biotechnology with the Record Date of Thursday, January 17, 2019, and a Payment Date of Monday, February 25, 2019.
The stock dividend will result in the issuance of 1 share in NuGenerex Immuno-Oncology for every 4 shares of Generex Biotechnology common stock owned.
This press release does not constitute legal advice. Investors are encouraged to solicit independent legal advice and to consult their independent investment brokerage firms as to record, payment, and ex-dividend dates and the application thereof to trades in the Company’s common stock in the context of the stock dividend.
About Generex Biotechnology Corp.
(0)
(0)
